State Street’s PAVmed PAVM Stock Holding History
Bought
Maintained
Sold
Other funds holding PAVM
TSC
VCM
VFT
TRCT
State Street's PAVM Position: Q1 2026 in Review
State Street sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 695 shares — an estimated $4.61K sold.
State Street first reported a position in PAVM in Q2 2020 and held it in 23 quarters. The position peaked at $22.7M in Q3 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.
- State Street reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
- State Street sold 695 PAVmed shares in Q1 2026, an estimated $4.61K.
- State Street first reported a position in PAVmed in Q2 2020 and held it in 23 quarters.
- State Street's PAVmed position peaked at $22.7M in Q3 2021.
- 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.